Founded in 1967 in the Unites States, NAMSA is the global industry leading Contract Research Organization (CRO) for preclinical and clinical medical device companies, and a global market leader in preclinical and biocompatibility testing. The company provides a comprehensive range of medical device CRO services such as testing, consulting, clinical services, and in vitro diagnostics.

Key Value Creation Levers :
• Strategic workshop organization with leading Japanese MedTech players.
• Strategic support to Japan local leadership, including Terumo strategic partnership.
• Introductions to MedTech companies of all sizes across Europe and Asia.
• Acquisition sourcing and execution across the US, Europe, and Asia.